Supriya Lifescience IPO: Shares of pharmaceutical company Supriya Lifescience Limited made an exceptional listing on Dalal Street on Tuesday. Supriya Lifescience shares were listed at 55% premium and were trading at Rs 425 per share when it opened on the Bombay Stock Exchange or ESB. This has increased to Rs 151 from its issue price at the upper end of the price range. On the National Stock Exchange or NSE, the shares were listed at Rs 421 per share according to the data. The public issue was underwritten nearly 72 times when it opened earlier this month and received an excellent reception from investors.
Supriya Lifescience is one of India’s leading manufacturers and suppliers of Active Pharmaceutical Ingredients (“APIs”), with an emphasis on research and development. Supriya Lifescience’s IPO price range has been set at Rs 265 to Rs 274 per share.
Supriya IPO had planned to increase Rs 700 crore at the high end of the price range, but had already raised Rs 315 crore through key investors who booked the show on December 15, a day before the opening of the show. Supriya Lifescience’s IPO includes a new issue valued at Rs 200 crore, while Rs 500 crore will be an offer to sell (OFS) for selling shareholders.
Read all the latest news, breaking news and news on the coronavirus here.